PMID- 19219407 OWN - NLM STAT- MEDLINE DCOM- 20090611 LR - 20220419 IS - 1559-0259 (Electronic) IS - 1530-7905 (Linking) VI - 9 IP - 1 DP - 2009 Mar TI - Acute myocardial infarction following oral methyl-ergometrine intake. PG - 46-8 LID - 10.1007/s12012-009-9031-9 [doi] AB - Ergot derivatives are frequently administrated during cesarean delivery, induced abortion, or post-partum hemorrhage to promote uterine contractions. Ergot derivatives may also induce coronary spasm and intravenous ergonovine is used in cardiac catheterization laboratories as a diagnostic agent. Serious ischemic cardiac events related to ergonovine are rare and have most often been described after intravenous use. We report the case of a 38-year-old woman with a ST elevation myocardial infarction (STEMI) few days after artificially induced abortion by oral prescription of methylergometrine. Coronary angiography performed 2 days after onset of chest pain did not reveal any abnormalities of the coronary arteries but a provocative test using intravenous methylergometrine was positive with reproduction of chest pain, ECG changes and with a significant narrowing localized on the second segment of the left anterior descending artery at the angiogram. Thus, since methylergometrin may clearly induce coronary spasm when prescribed orally, chest pain occurring under oral treatment should require immediate attention even if atypical or in the absence of cardiovascular risk factors. FAU - de Labriolle, Axel AU - de Labriolle A AD - Service de Cardiologie, Pole Coeur Thorax Vasculaire Hemostase, Centre Hospitalier Universitaire Trousseau, 37044, Tours, France. a.delabriolle@chu-tours.fr FAU - Genee, Olivier AU - Genee O FAU - Heggs, Laurens Mitchell AU - Heggs LM FAU - Fauchier, Laurent AU - Fauchier L LA - eng PT - Case Reports PT - Journal Article DEP - 20090214 PL - United States TA - Cardiovasc Toxicol JT - Cardiovascular toxicology JID - 101135818 RN - 0 (Abortifacient Agents) RN - 0 (Oxytocics) RN - 0 (Vasodilator Agents) RN - W53L6FE61V (Methylergonovine) SB - IM MH - Abortifacient Agents/administration & dosage/*adverse effects MH - Administration, Oral MH - Adult MH - Angina Pectoris/chemically induced MH - Coronary Angiography MH - Coronary Vasospasm/*chemically induced/diagnosis/drug therapy MH - Drug Therapy, Combination MH - Electrocardiography MH - Female MH - Humans MH - Methylergonovine/administration & dosage/*adverse effects MH - Myocardial Infarction/*chemically induced/diagnosis/drug therapy MH - Oxytocics/administration & dosage/*adverse effects MH - Vasodilator Agents/therapeutic use EDAT- 2009/02/17 09:00 MHDA- 2009/06/12 09:00 CRDT- 2009/02/17 09:00 PHST- 2009/01/12 00:00 [received] PHST- 2009/01/29 00:00 [accepted] PHST- 2009/02/17 09:00 [entrez] PHST- 2009/02/17 09:00 [pubmed] PHST- 2009/06/12 09:00 [medline] AID - 10.1007/s12012-009-9031-9 [doi] PST - ppublish SO - Cardiovasc Toxicol. 2009 Mar;9(1):46-8. doi: 10.1007/s12012-009-9031-9. Epub 2009 Feb 14.